Medication

At 36 weeks in the TOGETHER-PsO study, concomitant Taltz and Zepbound met primary endpoint of superiority vs. Taltz monotherapy…

Share on PinterestPeople who lose weight with GLP-1 drugs are likely to continue using the medication despite the…

Counterfeit prescription pills laced with fentanyl have flooded the U.S. drug market, a report revealed. These fake pills…

Albia Resident Accused of Stealing Medications from Pella Nursing Facility Pleads Guilty to Two Counts | KNIA KRLS…

Patients have been urged to ration supplies of the painkiller co-codamol amid a UK-wide shortage expected to last…

Samsung Health is extremely feature-rich. It can display your health data, such as physical activities, sleep, heart rate,…

NHS says only half the usual supply of prescription-strength is expected to be available until June. UK households…

RIYADH — The Ministry of Health said dispensing restricted medications such as antibiotics and weight-loss injections without a…

Chronic shortages of ADHD medication have been Pharmac’s “most significant supply issue”, according to a ministerial briefing obtained…

WASHINGTON (TNND) — Popular GLP-1 weight-loss medications have helped millions of people shed pounds, but new research from…

New prescriptions for puberty blockers were to be banned by the Government just before Christmas, but an urgent…

President Donald Trump launched TrumpRx.gov earlier this month to lower the cost of many popular medicines by offering…

Lilly’s Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight